Quadrivalent Human Papillomavirus Articles

Stock Commentary - New York week to July 7, 2008

14 July 2008

Prix Galien for Merck & Co's Gardasil and Januvia

27 September 2007

GSK's Cervarix does not increase HPV clearance in those already infected

20 August 2007

Global pharmaceutical market grew 7% to reach $643 billion, IMS reports

2 April 2007

Merck & Co's 4th-qtr income plunges 58%

5 February 2007

Merck & Co predicts more NDA filings in 2007 and highlights strong drug pipeline

22 December 2006

Sanofi Pasteur-MSD cancer drug promises strong growth, the company says

22 December 2006

US CDC recommends human papilloma virus vaccination with Merck & Co's Gardasil

10 July 2006

US FDA approves Merck & Co's Gardasil: First cervical cancer vacc, potential blockbuster

19 June 2006

UPDATE: ASCO 2006 another success, with strong new cancer drug data

12 June 2006

GSK's sees strong efficacy across wide age group

12 June 2006

Gardasil gets FDA nod for cervical cancer

29 May 2006

Merck & Co's Rotateq gets FDA OK

13 February 2006

US FDA accepts Merck's Gardasil BLA

13 February 2006

Sanofi Pasteur MSD to submit MAA to EMEA for Gardasil

19 December 2005

Gardisil: higher efficacy in young adolescents

30 May 2005

Showing 1-16 of 16 articles

Go to beginningPrevious
  • 1
NextGo to end